(Q24656098)

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

Screening and prostate-cancer mortality in a randomized European study

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

The natural history of invasive breast cancers detected by screening mammography

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

Skin biopsy rates and incidence of melanoma: population based ecological study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

The role of increasing detection in the rising incidence of prostate cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

Clinical responses to undiluted and diluted smallpox vaccine

30 May 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP278

Ramifications of screening for breast cancer: 1 in 4 cancers detected by mammography are pseudocancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP278

Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP278

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJP278

Neuroblastoma Screening at One Year of Age

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2758309

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

28 November 2018

1 reference

12 December 2020

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

1 reference

12 December 2020

Spontaneous regression of localized neuroblastoma detected by mass screening

1 reference

12 December 2020

Role of transurethral resection of the prostate in population-based prostate cancer incidence rates

1 reference

12 December 2020

Increasing incidence of thyroid cancer in the United States, 1973-2002

1 reference

12 December 2020

Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJP278

1 reference

1 reference

1 reference

PubMed publication ID

19720969

1 reference